Thomas J Gin1, Noha Ali1,2, Sivashanth Gnanasekaran1, Lauren A B Hodgson1, Lyndell L Lim1, Sukhpal S Sandhu1, Sanjeewa S Wickremasinghe3. 1. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, VIC, 3002, Australia. 2. Department of Ophthalmology, Faculty of Medicine, Assiut University, Assiut, Egypt. 3. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Level 1, 32 Gisborne Street, East Melbourne, VIC, 3002, Australia. swi@unimelb.edu.au.
Abstract
PURPOSE: To evaluate the acute effects of caffeine and glucose intake on retinal vascular calibre of healthy adults. METHODS: This prospective crossover study was conducted at the Centre for Eye Research Australia (Melbourne, Australia). Standardized doses of 300 mg caffeine (approximately 3 cups coffee), 30 g glucose or 300 ml of water, were each given to 19 healthy subjects on separate days. Retinal photographs and blood pressure measurements were taken at baseline, 30-, 60- and 120-min after ingestion of each solution. Central retinal artery and vein equivalents (CRAE, CRVE) and the arterio-venule ratio were measured using computer-assisted software. The mean retinal vascular calibre measurements were compared between pre- and post-ingestion images. RESULTS: After caffeine intake, significant reductions were observed in mean CRAE of - 9.3 μm, - 10.4 μm and - 8.5 μm and CRVE of - 16.9 μm, - 18.7 μm and - 16.1 μm at 30-, 60- and 120-min after intake when compared with baseline (p ≤ 0.002 for all; paired t test). No significant changes were observed in mean retinal vascular calibre measurements after intake of either glucose or water when compared to baseline (p ≥ 0.072 for all). When controlling for baseline characteristics and blood pressure measurements, only caffeine intake had a significant effect on reducing both CRAE and CRVE at all time points post ingestion (p ≤ 0.003 for all, multiple linear regression model). CONCLUSION: Caffeine is associated with an acute vasoconstrictive effect on retinal arterioles and venules in healthy subjects. Factors other than blood pressure-induced autoregulation play a significant role in caffeine-associated retinal vasoconstriction.
PURPOSE: To evaluate the acute effects of caffeine and glucose intake on retinal vascular calibre of healthy adults. METHODS: This prospective crossover study was conducted at the Centre for Eye Research Australia (Melbourne, Australia). Standardized doses of 300 mg caffeine (approximately 3 cups coffee), 30 g glucose or 300 ml of water, were each given to 19 healthy subjects on separate days. Retinal photographs and blood pressure measurements were taken at baseline, 30-, 60- and 120-min after ingestion of each solution. Central retinal artery and vein equivalents (CRAE, CRVE) and the arterio-venule ratio were measured using computer-assisted software. The mean retinal vascular calibre measurements were compared between pre- and post-ingestion images. RESULTS: After caffeine intake, significant reductions were observed in mean CRAE of - 9.3 μm, - 10.4 μm and - 8.5 μm and CRVE of - 16.9 μm, - 18.7 μm and - 16.1 μm at 30-, 60- and 120-min after intake when compared with baseline (p ≤ 0.002 for all; paired t test). No significant changes were observed in mean retinal vascular calibre measurements after intake of either glucose or water when compared to baseline (p ≥ 0.072 for all). When controlling for baseline characteristics and blood pressure measurements, only caffeine intake had a significant effect on reducing both CRAE and CRVE at all time points post ingestion (p ≤ 0.003 for all, multiple linear regression model). CONCLUSION: Caffeine is associated with an acute vasoconstrictive effect on retinal arterioles and venules in healthy subjects. Factors other than blood pressure-induced autoregulation play a significant role in caffeine-associated retinal vasoconstriction.
Authors: Tien Yin Wong; F M Amirul Islam; Ronald Klein; Barbara E K Klein; Mary Frances Cotch; Cecilia Castro; A Richey Sharrett; Eyal Shahar Journal: Invest Ophthalmol Vis Sci Date: 2006-06 Impact factor: 4.799
Authors: T Y Wong; R Klein; D J Couper; L S Cooper; E Shahar; L D Hubbard; M R Wofford; A R Sharrett Journal: Lancet Date: 2001-10-06 Impact factor: 79.321
Authors: Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; James M Tielsch; Barbara E K Klein; Larry D Hubbard Journal: JAMA Date: 2002-03-06 Impact factor: 56.272
Authors: Tien Yin Wong; Bruce B Duncan; Sherita Hill Golden; Ronald Klein; David J Couper; Barbara E K Klein; Larry D Hubbard; A Richey Sharrett; Maria I Schmidt Journal: Invest Ophthalmol Vis Sci Date: 2004-09 Impact factor: 4.799
Authors: Thanh Tan Nguyen; Jie Jin Wang; A Richey Sharrett; F M Amirul Islam; Ronald Klein; Barbara E K Klein; Mary Frances Cotch; Tien Yin Wong Journal: Diabetes Care Date: 2007-12-10 Impact factor: 19.112